SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW, 'Crow With Knife,' is captivating the crypto community, trending with enthusiastic discussions around its unique multichain presence across platforms like Solana, Cronos, Ethereum, and Binance Smart Chain. The conversation emphasizes its deflationary 'bridge-burn mechanism' and a strong belief among supporters that it is a standout meme coin, often referred to as 'the only option' for engagement. Many users are calling it the 'king of the memes' and 'the real deal.'

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc - ADR

AstraZeneca PLC

AstraZeneca is trending due to a flurry of positive clinical trial data and recent regulatory approvals across its oncology portfolio, including significant advancements for Enhertu in breast cancer and Tagrisso in lung cancer. Community discussion is actively centered on the company's strategic commitment to expand its U.S. manufacturing with a substantial investment, particularly in light of drug pricing negotiations and a potential tariff exemption deal with the Trump administration. Investors are also noting AZN's planned full NYSE listing, viewing it as a robust and diversifying pharmaceutical leader.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is experiencing an explosive short squeeze, largely attributed to its low float and an AI-related deal. The community is actively comparing its parabolic surge to past runners like SMX, with many celebrating the squeeze and debating the sustainability of its extreme volatility and upward momentum.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo (BTGO) is trending due to a significant post-IPO decline, with shares falling sharply after initially opening above the offer price. This sharp drop is fueling intense community debate, as many draw comparisons to other volatile crypto-related IPOs, while others highlight the company's institutional digital asset custody business, reported profitability, and federal bank charter as reasons for a potential rebound.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is trending following reports of record asset under management and strategic growth, sparking community discussion around its aggressive expansion into AI data center and renewable energy infrastructure through potential acquisitions. The firm's deepening involvement in digital assets and tokenization initiatives is also a key talking point, alongside speculation surrounding a BlackRock executive as a prominent contender for a top economic leadership role.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending due to its announced record preliminary revenue and promising 2026 guidance, alongside the significant milestone of its Eversense 365 long-term CGM integrating with the twiist automated insulin delivery system. The community is actively discussing this breakthrough integration, which many view as a game-changer for its superior technology and improved market positioning, even as some express frustration with management's communication and slow commercialization pace. This puts the spotlight on SENS amidst broader competition and ongoing speculation about future partnerships.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is experiencing strong upward momentum following the FDA approval of its game-changing twice-yearly HIV prevention drug, Yeztugo, alongside robust Q2 earnings that exceeded expectations and a raised full-year outlook. The community is actively discussing how this solidifies Gilead's leading HIV franchise while highlighting its aggressive expansion into oncology through recent strategic acquisitions and partnerships. This diversification and renewed pipeline strength are fueling investor optimism, with the stock recently breaking out to new highs within the competitive biotech sector.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is a central topic of discussion due to its strategic acquisitions, notably Celestial AI, which firmly position it at the forefront of optical interconnects and custom AI silicon for data centers. The community is actively highlighting how these moves are critical for scaling next-generation AI systems, driving conversation around its foundational role for major hyperscalers and the belief that the stock is currently undervalued.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is gaining attention due to its aggressive store expansion in China and its strategic entry into competitive markets like New York City, which analysts are noting for its significant growth potential. Despite strong operational fundamentals and favorable comparisons to traditional coffee giants, community conversation highlights ongoing frustration over the stock's performance on the OTC market and the lack of clarity surrounding a potential uplisting.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following the approved acquisition of Astria Therapeutics, a move expected to strengthen its HAE pipeline with late-stage asset navenibart and bring in new leadership under CEO Charlie Gayer. The community is actively discussing the impact of new share dilution from the merger and recently released conservative revenue guidance for the upcoming year, though a significant increase in ORLADEYO's wholesale acquisition cost is seen as a positive offset. Many investors are expressing a mix of hope for improved shareholder value under new management and frustration over the stock's historical performance, questioning if strategic actions can overcome persistent market challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
